Amgen Europe B.V.
SpainAll drugs from this manufacturer
-
It is used to treat various inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, Crohn's disease, ulcerative colitis, hidradenitis suppurativa, ankylosing spondylitis, non-infectious uveitis, and other joint or skin conditions.
Dosage form: solution for injection
Active substance Dosage adalimumab 20 mg -
What is AMGEVITA used for? :
Dosage form: solution for injection
Active substance Dosage adalimumab 40 mg -
It is used to treat various inflammatory diseases, such as rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, Crohn's disease, ulcerative colitis, hidradenitis suppurativa, ankylosing spondylitis, non-infectious uveitis, and polyarticular juvenile idiopathic arthritis.
Dosage form: solution for injection
Active substance Dosage adalimumab 40 mg -
It is used to treat anemia, which is when the blood does not have enough red blood cells. It is specifically prescribed to treat anemia associated with chronic kidney failure in adults and children, or in adult patients with non-myeloid tumors who are receiving chemotherapy.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage darbepoetin alfa 0,025 mg -
It is used to treat symptomatic anemia in adults and children with chronic renal failure, as well as in adult patients with non-myeloid tumors undergoing chemotherapy.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage darbepoetin alfa 100 µg -
It is used to treat symptomatic anemia in adults and children with chronic renal failure, as well as in adult patients with non-myeloid tumors who are receiving chemotherapy.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage darbepoetin alfa 300 µg -
It is used to treat symptomatic anemia associated with chronic renal failure in adults and children, as well as in adult patients with non-myeloid tumors receiving chemotherapy.
Dosage form: solution for injection in pre-filled pen
Active substance Dosage darbepoetin alfa 150 µg -
It is used to treat symptomatic anemia in adults and children with chronic renal failure, as well as in adult patients with non-myeloid tumors undergoing chemotherapy.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage darbepoetin alfa 150 µg -
It is used to treat symptomatic anemia associated with chronic renal failure in adults and children, as well as symptomatic anemia in adult patients with non-myeloid tumors receiving chemotherapy.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage darbepoetin alfa 20 µg -
It is used to treat symptomatic anemia associated with chronic renal failure in adults and children, as well as in adult patients with non-myeloid tumors undergoing chemotherapy.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage darbepoetin alfa 30 µg -
It is used to treat symptomatic anemia in adults and children with chronic renal failure, as well as in adult patients with non-myeloid tumors who are receiving chemotherapy.
Dosage form: solution for injection in pre-filled pen
Active substance Dosage darbepoetin alfa 300 µg -
It is used to treat symptomatic anemia associated with chronic renal failure in adults and children, as well as anemia in adult patients with non-myeloid tumors receiving chemotherapy.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage darbepoetin alfa 300 µg -
It is used to treat symptomatic anemia in adults and children with chronic renal failure, as well as in adult patients with non-myeloid tumors who are receiving chemotherapy.
Dosage form: solution for injection in pre-filled pen
Active substance Dosage darbepoetin alfa 40 µg -
It is used to treat symptomatic anemia in adults and children with chronic renal failure, as well as in adult patients with non-myeloid tumors receiving chemotherapy.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage darbepoetin alfa 40 µg -
It is used to treat symptomatic anemia in adults and children with chronic renal failure, as well as in adult patients with non-myeloid tumors undergoing chemotherapy.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage darbepoetin alfa 50 µg -
It is used to treat symptomatic anemia in adults and children with chronic renal failure, as well as in adult patients with non-myeloid tumors who are receiving chemotherapy.
Dosage form: solution for injection in pre-filled pen
Active substance Dosage darbepoetin alfa 500 µg -
It is used to treat symptomatic anemia in adults and children with chronic renal failure, as well as in adult patients with non-myeloid tumors who are receiving chemotherapy.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage darbepoetin alfa 500 µg -
It is used to treat symptomatic anemia in adults and children with chronic renal failure, and in adult patients with non-myeloid tumors who are receiving chemotherapy.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage darbepoetin alfa 60 µg -
It is used to treat symptomatic anemia in adults and children with chronic renal failure, as well as in adult patients with non-myeloid tumors undergoing chemotherapy.
Dosage form: solution for injection in pre-filled pen
Active substance Dosage darbepoetin alfa 80 µg -
It is used to treat symptomatic anemia in adults and children with chronic renal failure, and in adult patients with non-myeloid tumors who are receiving chemotherapy.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage darbepoetin alfa 80 µg -
It is used to treat adults, children, and young adults with acute lymphoblastic leukemia, specifically when the disease recurs, has not responded to previous treatments, or when small amounts of cancer cells persist after treatment.
Dosage form: powder for concentrate and solution for infusion
Active substance Dosage blinatumomab 38,5 µg -
It is used for the treatment of breast cancer (early or metastatic) and metastatic gastric cancer, provided that the tumor cells have high levels of a protein called HER2.
Dosage form: powder for concentrate for solution for infusion
Active substance Dosage trastuzumab 156 mg -
It is used to treat early or metastatic breast cancer and metastatic gastric cancer, provided that the tumor cells have high levels of a protein called HER2.
Dosage form: powder for concentrate for solution for infusion
Active substance Dosage trastuzumab 440 mg -
It is used to treat adult patients with multiple myeloma (a type of plasma cell cancer) who have already received at least one previous treatment for this disease.
Dosage form: powder for solution for injection
Active substance Dosage carfilzomib 10 mg -
It is used to treat adult patients with multiple myeloma (a type of plasma cell cancer) who have already received at least one previous treatment for this disease.
Dosage form: powder for solution for injection
Active substance Dosage carfilzomib 30 mg -
It is used to treat adult patients with multiple myeloma (a type of cancer of plasma cells) who have already received at least one prior treatment for this disease.
Dosage form: powder for solution for infusion
Active substance Dosage carfilzomib 60 mg -
It is used to treat adult patients with a type of lung cancer called non-small cell lung cancer (NSCLC) in advanced stages that has spread to other parts of the body, provided that the cancer cells have a specific genetic mutation (KRAS G12C) and previous treatments have not worked.
Dosage form: tablets, film-coated
Active substance Dosage sotorasib 240 mg -
It is used to reduce the duration and frequency of neutropenia (low white blood cell count) and febrile neutropenia that may occur after receiving chemotherapy.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage pegfilgrastim 6 mg -
It is used to increase the white blood cell count in various situations, such as after chemotherapy treatment or a bone marrow transplant, to prevent infections, in cases of severe chronic neutropenia, or in patients with advanced HIV infection.
Dosage form: solution for injection and for infusion
Active substance Dosage filgrastim 0,3 mg -
It is used to increase the white blood cell count in cases of neutropenia (reduction of white blood cells) following chemotherapy or a bone marrow transplant, to prevent infections in patients with severe chronic neutropenia or advanced HIV infection, and before high-dose chemotherapy.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage filgrastim 0,3 mg -
It is used to increase the white blood cell count in various situations, such as after chemotherapy treatment or a bone marrow transplant, to prevent infections, in cases of severe chronic neutropenia, or in patients with advanced HIV infection.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage filgrastim 0,48 mg -
It is used in adults with immune thrombocytopenia (ITP), a disease in which the immune system destroys platelets, to help increase their count and prevent bruising or bleeding.
Dosage form: powder and solvent for solution for injection
Active substance Dosage romiplostim 250 µg -
It is used to treat low platelet counts in adult patients with immune thrombocytopenia (ITP) who have not responded to other treatments, and in children 1 year of age or older with chronic ITP who have also not responded to corticosteroids or immunoglobulins.
Dosage form: powder for solution for injection
Active substance Dosage romiplostim 250 µg -
It is used to treat low platelet counts in adults with immune thrombocytopenia (ITP), a disease in which the immune system destroys the body's own platelets.
Dosage form: powder and solvent for solution for injection
Active substance Dosage romiplostim 500 µg -
It is used to treat secondary hyperparathyroidism in people with severe kidney disease who require hemodialysis.
Dosage form: solution for injection
Active substance Dosage etelcalcetide hydrochloride 12,3 mg -
It is used to treat secondary hyperparathyroidism in patients with severe kidney disease who require hemodialysis.
Dosage form: solution for injection
Active substance Dosage etelcalcetide hydrochloride 3,1 mg -
It is used to treat secondary hyperparathyroidism in patients with severe kidney disease who require hemodialysis to remove waste from the blood.
Dosage form: solution for injection
Active substance Dosage etelcalcetide hydrochloride 6,2 mg -
It is used to treat osteoporosis in postmenopausal women and in men at risk of fracture. It is also used to treat bone loss caused by testosterone reduction in patients with prostate cancer or by long-term glucocorticoid use in individuals at risk of fracture.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage denosumab 60 mg -
It is used to reduce 'bad' cholesterol levels in the blood as an adjunct to diet. It is indicated for adults and children aged 10 years and older with high cholesterol levels due to various conditions, such as primary hypercholesterolemia, mixed dyslipidemia, or familial disorders (heterozygous or homozygous), as well as for adults with established cardiovascular disease.
Dosage form: solution for injection in pre-filled pen
Active substance Dosage evolocumab 140 mg/ml -
It is used to reduce 'bad' cholesterol levels in the blood as an adjunct to diet. It is indicated for adults and children (from 10 years of age) with high cholesterol levels due to various disorders or with established cardiovascular disease.
Dosage form: solution for injection in pre-filled pen
Active substance Dosage evolocumab 140 mg/ml -
It is used to treat adults with three rare diseases: neuromyelitis optica spectrum disorder (NMOSD), IgG4-related disease (IgG4-RD), and generalized myasthenia gravis (gMG).
Dosage form: solution for infusion, concentrate
Active substance Dosage inebilizumab 10 mg/ml -
It is used to treat metastatic colorectal cancer (bowel cancer) in adults who have a type of tumor with non-mutated RAS.
Dosage form: solution for infusion, concentrate
Active substance Dosage panitumumab 20 mg -
It is used to treat metastatic colorectal cancer (bowel cancer) in adults who have a specific type of tumor called 'RAS wild-type tumors'.
Dosage form: solution for infusion, concentrate
Active substance Dosage panitumumab 20 mg -
It is used in adults to prevent serious complications caused by bone metastases (such as fractures or spinal cord compression) and to treat giant cell tumor of the bone in adults and adolescents whose bones have stopped growing.
Dosage form: solution for injection
Active substance Dosage denosumab 120 mg